Pharmaceutical Development

Temporary importation of Erwinase® (crisantaspase) injection, powder, lyophilized, for solution to address a drug shortage in the United States (U.S.)

Porton Biopharma Limited (via its distributor Clinigen Inc.) in conjunction with FDA has initiated a temporary importation of Crisantapase (Erwinase®) 10,000 IU/vial powder for solution, to the U.S. market to address drug shortage.
Further information can be found as follows:

 

To place an order, please contact McKesson Plasma and Biologics directly at 1-877-625-2566.